Related Experiment Videos
Fetal sacrococcygeal teratoma
R S Kuhlmann1, S L Warsof, D L Levy
1Division of Maternal Fetal-Medicine, Eastern Virginia Medical School, Norfolk.
Fetal Therapy
|January 1, 1987
Summary
Early diagnosis of fetal sacrococcygeal teratoma (SCT) allows for perinatal management. Prenatal intervention may be possible for fetal SCT diagnosed in the second trimester.
Area of Science:
- Perinatal medicine
- Fetal surgery
- Developmental biology
Background:
- Sacrococcygeal teratoma (SCT) is a common congenital tumor.
- Early prenatal diagnosis enables timely intervention.
- Fetal SCT exhibits distinct behavior compared to neonatal SCT.
Observation:
- This study expands on previous findings with 2 new cases, totaling 29.
- One case represents the earliest diagnosis of fetal SCT to date.
- Fetal SCT behavior differs significantly from neonatal presentations.
Findings:
- Early prenatal diagnosis of SCT facilitates perinatal management strategies.
- In utero interventions for fetal SCT may be feasible with second-trimester diagnosis.
- Management approaches can be tailored based on gestational age at diagnosis.
Implications:
- Advances in prenatal diagnosis can improve outcomes for infants with SCT.
- Potential for in utero treatment could revolutionize fetal medicine.
- Further research into second-trimester SCT management is warranted.